• Apr 3, 2025BRICS to counter US tariffs | SHL opens $220M US autoinjector site | Q&A: Lonza’s new operating model
    Apr 2, 2025Tariffs on drugs made in Canada expected to increase costs by $750M | Cellares gets FDA Advanced Manufacturing Technology designation
    Apr 1, 2025Curium acquires Monrol, becomes top Lu-177 producer | DHL buys CRYOPDP to expand pharma logistics
    Mar 29, 2025Resilience expands Ohio biomanufacturing, adds 200 jobs | Singota opens temperature-controlled facility in Switzerland
    Mar 28, 2025Amgen, Biogen face highest risk from Trump’s proposed drug tariffs | Chiesi buys Italy plant in $465M investment
    Mar 27, 2025US biotechs fear cost surge from tariffs on EU imports | Benuvia wins NIH contract for GMP psilocybin
    Mar 26, 2025WuXi Biologics reports 9.6% revenue growth in 2024, eyes faster growth in 2025 | Carbogen Amcis gains GMP nod for French drug product site
    Mar 25, 2025US bioeconomy could hit $416B by 2030 | FDA again rejects liver cancer drug combo over manufacturing issues
    Mar 22, 2025J&J plans $55B US investment with four new sites | AstraZeneca’s $2.5B expansion in China
    Mar 21, 2025Ori Biotech launches partner network for cell and gene therapy manufacturing | Currax gains FDA nod for second weight-loss drug site
    Mar 20, 2025Cellares, Cabaletta Bio automate cell therapy manufacturing | Delpharm secures $60M for facility upgrades
    Mar 19, 2025WuXi AppTec posts record Q4 revenue, downplays BIOSECURE Act | Avantor highlights hydration expansion at DCAT 2025
    Mar 18, 2025Humanetics selects Lifecore for CDMO services | Lotte Biologics, Asimov partner on cell line development
    Mar 15, 2025Samsung Biologics expands Bio Campus II in South Korea | Recipharm reports record 2024 revenue driven by biologics
    Mar 14, 2025Entos Pharma secures $137M for Edmonton facility | Almac opens $84M site in Northern Ireland
    Mar 13, 2025Merck opens $1B vaccine plant in North Carolina | Legend Biotech to double Carvykti output in 2025
    Mar 12, 2025CordenPharma lands $150M GLP-1/GIP manufacturing deal | Syngene acquires first U.S. biologics site for $36.5M
    Mar 11, 2025Lilly’s $27B US investment won’t boost production soon | EU ministers warn of ‘dangerous’ reliance on Asia for meds
    Mar 8, 2025Enzene earns EU GMP certification for India sites | Lonza opens sustainability center to cut emissions
    Mar 7, 2025Merck KGaA’s CDMO sales dip in 2024 amid manufacturing investment | Micreos partners with Northway Biotech for endolysin production
    Mar 6, 2025Trump says reciprocal tariffs set to begin April 2 | FDA warns Granules India over cGMP violations
    Mar 5, 2025Pfizer may shift overseas manufacturing to US under Trump tariffs | Axplora expands ADC payload production in France
    Mar 4, 2025Thermo Fisher eyes 2025 growth | Eckert & Ziegler, Bicycle ink radiopharma deal
    Mar 1, 2025Lilly’s $27B US investment aims to win Trump’s favor | GAO: FDA still struggles with foreign drug inspections
    Feb 28, 2025FDA hits Piramal Pharma’s India API plant with Form 483 | Vaxcyte, Lonza advance pneumococcal vaccine manufacturing
    Latest Edition